A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder (BEACh study)
Brownley KA, Von Holle A, Hamer RM, La Via M, Bulik CM
Published in Journal of Psychosomatic Research
Methodology
6-month double-blind placebo-controlled pilot trial of 600 or 1000 mcg/day chromium picolinate in overweight adults with binge eating disorder
Key Findings
Fasting glucose fell significantly with chromium, but reductions in binge frequency, weight and depression were numerically greater yet not statistically significant
Conclusions
Chromium did not significantly reduce binge eating in this underpowered pilot
Limitations
Very small pilot sample, limited statistical power, surrogate metabolic endpoint
Supplements Studied
Fasting glucose was significantly reduced in both chromium groups compared to the placebo group
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
National Institutes of Health
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.